BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 29357982)

  • 21. [Schizophrenia and cortical GABA neurotransmission].
    Hashimoto T; Matsubara T; Lewis DA
    Seishin Shinkeigaku Zasshi; 2010; 112(5):439-52. PubMed ID: 20560363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell and receptor type-specific alterations in markers of GABA neurotransmission in the prefrontal cortex of subjects with schizophrenia.
    Lewis DA; Hashimoto T; Morris HM
    Neurotox Res; 2008 Oct; 14(2-3):237-48. PubMed ID: 19073429
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anterior Cingulate Glutamate and GABA Associations on Functional Connectivity in Schizophrenia.
    Shukla DK; Wijtenburg SA; Chen H; Chiappelli JJ; Kochunov P; Hong LE; Rowland LM
    Schizophr Bull; 2019 Apr; 45(3):647-658. PubMed ID: 29912445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Markedly Lower Glutamic Acid Decarboxylase 67 Protein Levels in a Subset of Boutons in Schizophrenia.
    Rocco BR; Lewis DA; Fish KN
    Biol Psychiatry; 2016 Jun; 79(12):1006-15. PubMed ID: 26364548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. GABA transporter-1 mRNA in the prefrontal cortex in schizophrenia: decreased expression in a subset of neurons.
    Volk D; Austin M; Pierri J; Sampson A; Lewis D
    Am J Psychiatry; 2001 Feb; 158(2):256-65. PubMed ID: 11156808
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential gene expression in layer 3 pyramidal neurons across 3 regions of the human cortical visual spatial working memory network.
    Enwright Iii JF; Arion D; MacDonald WA; Elbakri R; Pan Y; Vyas G; Berndt A; Lewis DA
    Cereb Cortex; 2022 Nov; 32(22):5216-5229. PubMed ID: 35106549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia.
    Eggan SM; Hashimoto T; Lewis DA
    Arch Gen Psychiatry; 2008 Jul; 65(7):772-84. PubMed ID: 18606950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laminar-Specific Alterations in Calbindin-Positive Boutons in the Prefrontal Cortex of Subjects With Schizophrenia.
    Fish KN; Rocco BR; Wilson JD; Lewis DA
    Biol Psychiatry; 2023 Jul; 94(2):142-152. PubMed ID: 36868891
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Disrupted GABAergic facilitation of working memory performance in people with schizophrenia.
    Ragland JD; Maddock RJ; Hurtado MY; Tanase C; Lesh TA; Niendam TA; Carter CS; Ranganath C
    Neuroimage Clin; 2020; 25():102127. PubMed ID: 31864216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Alterations in cortical interneurons and cognitive function in schizophrenia.
    Dienel SJ; Lewis DA
    Neurobiol Dis; 2019 Nov; 131():104208. PubMed ID: 29936230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dysfunctional glutamatergic and γ-aminobutyric acidergic activities in prefrontal cortex of mice in social defeat model of depression.
    Veeraiah P; Noronha JM; Maitra S; Bagga P; Khandelwal N; Chakravarty S; Kumar A; Patel AB
    Biol Psychiatry; 2014 Aug; 76(3):231-8. PubMed ID: 24239130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of cannabidiol on endocannabinoid, glutamatergic and GABAergic signalling markers in male offspring of a maternal immune activation (poly I:C) model relevant to schizophrenia.
    Osborne AL; Solowij N; Babic I; Lum JS; Newell KA; Huang XF; Weston-Green K
    Prog Neuropsychopharmacol Biol Psychiatry; 2019 Dec; 95():109666. PubMed ID: 31202911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics.
    Akbarian S; Kim JJ; Potkin SG; Hagman JO; Tafazzoli A; Bunney WE; Jones EG
    Arch Gen Psychiatry; 1995 Apr; 52(4):258-66. PubMed ID: 7702443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. 7T Proton Magnetic Resonance Spectroscopy of Gamma-Aminobutyric Acid, Glutamate, and Glutamine Reveals Altered Concentrations in Patients With Schizophrenia and Healthy Siblings.
    Thakkar KN; Rösler L; Wijnen JP; Boer VO; Klomp DW; Cahn W; Kahn RS; Neggers SF
    Biol Psychiatry; 2017 Mar; 81(6):525-535. PubMed ID: 27316853
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Specific relationship between prefrontal neuronal N-acetylaspartate and activation of the working memory cortical network in schizophrenia.
    Bertolino A; Esposito G; Callicott JH; Mattay VS; Van Horn JD; Frank JA; Berman KF; Weinberger DR
    Am J Psychiatry; 2000 Jan; 157(1):26-33. PubMed ID: 10618009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduced
    Wang J; Tang Y; Zhang T; Cui H; Xu L; Zeng B; Li Y; Li G; Li C; Liu H; Lu Z; Zhang J; Wang J
    Neural Plast; 2016; 2016():3915703. PubMed ID: 28003912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Altered cortical expression of GABA-related genes in schizophrenia: illness progression vs developmental disturbance.
    Hoftman GD; Volk DW; Bazmi HH; Li S; Sampson AR; Lewis DA
    Schizophr Bull; 2015 Jan; 41(1):180-91. PubMed ID: 24361861
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dorsolateral Prefrontal Cortex GABA Concentration in Humans Predicts Working Memory Load Processing Capacity.
    Yoon JH; Grandelis A; Maddock RJ
    J Neurosci; 2016 Nov; 36(46):11788-11794. PubMed ID: 27852785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction.
    Volk DW; Lewis DA
    Physiol Behav; 2002 Dec; 77(4-5):501-5. PubMed ID: 12526990
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oscillatory, Computational, and Behavioral Evidence for Impaired GABAergic Inhibition in Schizophrenia.
    Shaw AD; Knight L; Freeman TCA; Williams GM; Moran RJ; Friston KJ; Walters JTR; Singh KD
    Schizophr Bull; 2020 Feb; 46(2):345-353. PubMed ID: 31219602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.